CRMD Q2 2024 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$806,119

Gross Profit

$296,28036.8% margin

Operating Income

-$15M-1898.1% margin

Net Income

-$14M-1755.5% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$58M

Total Liabilities

$12M

Stockholders' Equity

$46M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$806,119	$0	—
Gross Profit	$296,280	-$50,748	+683.8%
Operating Income	-$15M	-$12M	-29.6%
Net Income	-$14M	-$11M	-25.5%